Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 19 (RPS2P19) is classified as a processed pseudogene of the ribosomal protein S2 (RPS2) gene family[3]. Pseudogenes are non-functional segments of DNA that resemble protein-coding genes but typically lack the capability to encode a functional protein due to mutations or lack of necessary regulatory elements[3][6]. RPS2P19 does not encode an active ribosomal protein, does not participate in cellular ribosome assembly, and is not linked to any known biological pathways, diseases, or drug interactions[3]. There is no evidence it acts as a therapeutic target or is involved in protein synthesis or ribosomopathies, unlike the parent RPS2 gene[2][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 19 (RPS2P19).